Delivery Order SPE2DB24D1205-SPE2DB24FCRXR
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,772.62 firm fixed-price delivery order is for the supply of FOLLISTIM AQ 600 UNIT CARTRIDG 0.72ML, a pharmaceutical product, with an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,548.25 firm fixed-price delivery order is for the supply of FOLLISTIM AQ 900 UNIT CARTRIDG 1.08ML, a medical product, with a completion date of November 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, with an ID of SPE2DB20D1109|SPE2DB25FN71U, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,427.81 firm-fixed-price delivery order is for FOLLISTIM AQ 900 UNIT CARTRIDG 1.08ML, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025 and was awarded on March 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,626.89 to AmerisourceBergen Drug Corp for Follistim AQ 900 Unit Cartridge (1.08 mL) with an ultimate completion date of January 8, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open solicitation process. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. AmerisourceBergen Drug Corp, a subsidiary of...
- This federal contract award, with ID SPE2DX15D1205|SPE2DX24F39P3, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $14,324.84 firm-fixed-price contract is for the delivery of Follistim AQ 600 unit cartridges, a specialty pharmaceutical product, with a period of performance through October 17, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $74,109.97 firm fixed-price delivery order is for the supply of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML medical products. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,734.62, is for the delivery of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML medical supplies. It is a firm fixed-price delivery order contract with a completion date of February 4, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $101,892.98, is for the delivery of Gonal-F RFF Redi-Ject 900 Unit 1.5ML medical supplies. The contract is a Firm Fixed Price delivery order with a performance period extending to February 3, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,679.92 firm fixed-price contract is for the supply of GONAL-F RFF REDI-JECT 300 UNIT 0.5ML, a medical product. The contract has an ultimate completion date of January 6, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of GONAL-F RFF REDI-JECT pharmaceutical products, with a total ceiling value of $5,198.00. The contract is a firm fixed-price delivery order, with an ultimate completion date of September 3, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB24FCRXRDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,047.14, is for the procurement of FOLLISTIM AQ 900 UNIT CARTRIDG 1.08ML, a pharmaceutical product. The contract has a completion date of June 11, 2024 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract is part of Amerisourcebergen's broader federal contract portfolio, which includes a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 6/10/24 |